Life Sciences
-
Portal Innovations kicks off $100 million Velocity Fund
Portal Innovations, established by John Flavin who previously set up the Polsky Center, partners with institutions like UChicago to support spinouts.
-
Medical University of South Carolina launches two funds totalling $30 million
The $20 million 1824 Health Ventures Fund I and the $10 million South Carolina Health Innovation Fund will both be managed by Bob Crutchfield.
-
Brandon Capital collects A$439 million for sixth fund
Australasian life sciences VC Brandon Capital has a partnership with more than 50 research institutions that provide access to deals.
-
Michigan State University unveils $10 million fund
The university is doubling down on its partnership with Henry Ford Health to create a $10 million fund and innovation hub.
-
Friday Five: EnAcuity, Filics, Gallion Health, ODOS, Plasma Fresh
Software that turns surgical cameras into hyperpectral imaging tools, a platform that helps farmers operate more sustainably, and cold plasma that kills foodborne pathogens are all becoming real applications thanks to these spinouts.
-
Catalio closes Nexus Fund IV with $400 million
Catalio Capital Management specialises in launching and investing in life sciences spinouts through a network of researchers that act as venture partners.
-
Friday Five: Aspecthera, Axiles, LayerLogic, Orinova, Peach Cars
We take a look at some of the early-stage spinouts that caught our eye. This week: Aspecthera, Axiles, LayerLogic, Orinova, Peach Cars
-
David O’Neill departs from FACIT
David O’Neill had been president of oncology-focused commercialisation firm Fight Against Cancer Innovation Trust since 2018. Peter Goodhand replaces him.
-
Friday Five: DigitalCNC, Draig Therapeutics, LastingAsset, RIFT, ScopeBio
We take a look at some of the early-stage spinouts that caught our eye. This time: DigitalCNC, Draig Therapeutics, LastingAsset, RIFT, and ScopeBio.
-
Biotope Ventures reaches €5 million first close for Fund II
Biotope Ventures, the accelerator and investment arm for Belgian research institute VIB, has raised €5 million towards a €9 million goal for its second fund.
-
Friday Five: Astratus, Hirundo, Lembas, OrisDX, and Somnee
We take a look at some of the early-stage spinouts that caught our eye. This time: Astratus, Hirundo, Lembas, OrisDX and Somnee.
-
Longview Innovation joins Anzu, forming the North America University Innovations Fund
Longview Innovation is joining forces with Anzu Partners and launching the North America University Innovations Fund.
-
Cancer Focus Fund targets $250m for second vehicle
The Cancer Focus Fund is affiliated with the University of Texas MD Anderson Cancer Center and is targeting about five times as much cash for Fund II.
-
Winsome Cheung: Startups, here’s what to know when negotiating with big pharma
Winsome Cheung is a partner at Covington who helps biotech startups and big pharma negotiate deals. Here, she shares what to look out for in contracts.
